Company is closed
Event Year: 2014
Company is closed
Event Year: 2014
Bikanta aimed to revolutionize medical imaging and diagnostics through its innovative nanodiamond-based technology. This groundbreaking approach sought to empower researchers and medical professionals by enabling them to address previously unanswerable questions and detect currently undetectable diseases. Nanodiamonds possess unique properties, including bright fluorescence, exceptional stability, non-toxicity, and functionalizability, making them ideal for background-free optical imaging. Initial findings demonstrated a significant signal enhancement, up to 100-fold, compared to traditional fluorescence imaging methods. Bikanta's overarching vision was to redefine the landscape of medical diagnostics by providing advanced imaging probes and facilitating background-free optical imaging techniques.
Bikanta aimed to revolutionize medical imaging and diagnostics through its innovative nanodiamond-based technology. This groundbreaking approach sought to empower researchers and medical professionals by enabling them to address previously unanswerable questions and detect currently undetectable diseases. Nanodiamonds possess unique properties, including bright fluorescence, exceptional stability, non-toxicity, and functionalizability, making them ideal for background-free optical imaging. Initial findings demonstrated a significant signal enhancement, up to 100-fold, compared to traditional fluorescence imaging methods. Bikanta's overarching vision was to redefine the landscape of medical diagnostics by providing advanced imaging probes and facilitating background-free optical imaging techniques.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2014
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2014
Healthcare
Healthcare
Healthcare -> Diagnostics
Healthcare -> Diagnostics
Team size: 2
Hiring: No
Team size: 2
Hiring: No